Cimpress plc (CMPR) Stock Forecast and Price Target (2026)

Sell-side coverage follows trading volume and banking relationships, so smaller companies, recent listings, and names outside the major indices often carry little or none. That is the situation with CMPR. It says nothing about the quality of the business, but it does mean there is no informed average to anchor to, and that any single target you find elsewhere is one analyst's model rather than a consensus.

At a market cap near $2.5 billion plus roughly $1.4 billion of net debt, Cimpress carries an enterprise value close to $4 billion, or under 10x its approximately $433 million of FY2025 adjusted EBITDA. Reported net income is thin because heavy interest and amortization sit below the EBITDA line, so the market tends to value the stock on EBITDA and free cash flow rather than GAAP earnings. Fiscal 2026 quarters showed revenue reaccelerating to double digits, which is central to management's path toward its stated $600 million EBITDA target by fiscal 2028.

Not a published one. Analyst price targets run to about twelve months, occasionally two years, and the firms covering CMPR do not put out a 2030 number. Anything presenting one is extrapolating a growth rate rather than reporting research, and a figure produced that way tells you about the assumption chosen, not about the company.

On the figures we hold as of September 2026, CMPR trades at about 23.2 times trailing earnings and 15.6 times forward earnings. A forward multiple below the trailing one means the market expects earnings to grow, and the size of that gap is roughly how much growth is already in the price.

That is the more useful frame for a ten-year question. A share price is the market’s estimate of future cash flows discounted to today, so the multiple is already a statement about growth. The long-horizon question is whether Cimpress plc can deliver what is priced in, and what would have to change for that to break. Both are answerable from the drivers and risks below. A number for 2030 is not.

In short: the drivers cited most often are Cash flow and per-share value focus, Vista as the growth and margin engine, Deleveraging toward a stronger balance sheet. The risk cited most often against it is the dominant risk is financial leverage: net debt of roughly $1.4 billion against negative book equity means interest expense and refinancing conditions materially affect the equity, and any EBITDA shortfall is magnified.

Both sides are worked through properly, with the high and low targets used as the bull and bear anchors, on the CMPR is it a buy page. This page deliberately stops at the numbers.